BREITBART – There is “low or very low quality” evidence that so-called “puberty blocker” drugs protect the mental health of minors who want to live as members of the opposite sex, says a report released by Florida Medicaid.
Florida’s 45-page report rebuts claims by transgender and transgender-affirming groups that puberty blockers are a safe fix for children and teenagers who are unhappy with their male or female bodies.
These groups include the World Professional Association for Transgender Health (WPATH), the Endocrine Society, and the American Academy of Pediatrics (AAP), and they are being cited as experts by large hospitals, Democrats, and the Biden administration, which wants to deliver the drugs to troubled children.
The report concluded that puberty blockers, cross-sex hormones, and sex change surgeries for adults and minors go against Medicaid’s rule, which mandates that sex reassignment treatments, as a condition of coverage, must be “consistent with generally accepted professional medical standards (GAPMS) and not experimental or investigational.”
The report was completed by Florida Medicaid and requested by the Secretary of the Agency for Health Care Administration (AHCA).
The report is significant because it could be used to inform the rule-making process for what types of treatments state health care agencies will be able to cover through programs like Medicaid …
The Florida Medicaid report is one of the latest pushback efforts from Florida Gov. Ron DeSantis against the Biden administration’s efforts to force the state to comply with radical leftist gender ideology.
In April, the Florida Department of Health released guidance on how to treat gender dysphoria in children and adolescents in response to the Biden administration’s plea for what it calls “gender-affirming” care, making it clear that social gender transition, as well as sex reassignment surgery, “should not be a treatment option for children or adolescents” … READ MORE.
